BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 5, 2015
View Archived Issues
Gene delivery therapy shows promising effects on experimental autoimmune myocarditis
Read More
AstraZeneca reviews recent pipeline activities of second quarter 2015
Read More
Novel potent and selective EP4 receptor antagonist for pain-management
Read More
Orkambi benefits patients with cystic fibrosis in phase III studies; product launch underway
Read More
The J. David Gladstone Institutes divulge autophagy inducers
Read More
Lilly designs FFAR1 agonists
Read More
Mitsubishi Tanabe Pharma presents milestones of first quarter of fiscal 2015
Read More
CSL completes acquisition of Novartis influenza vaccine business
Read More
First 3D printed drug product approved by FDA
Read More
FDA grants orphan drug designation to veltuzumab for ITP
Read More
The European Comission grants orphan drug designation to Soligenix's SGX-301
Read More
Exalenz Bioscience's BreathID to be tested in GR-MD-02 trial
Read More
Teva to buy controlling interest in analytics company Immuneering
Read More
Euclises Pharmaceuticals patents COX-2 inhibitors/NO-releasing prodrugs
Read More
Columbia University in the City of New York discloses SLC7A11 inhibitors
Read More
3-V Biosciences describes fatty acid synthase inhibitors
Read More
Merck Patent synthesizes IRAK inhibitors
Read More
Celgene exercises option to license GI-6207
Read More
Progenics forms agreement with Johns Hopkins University for prostate cancer imaging agent
Read More
CureVac and Gates Foundation to collaborate on RSV vaccine development
Read More
Minerva Biotechnologies licenses iPSC IP from iPS Academia Japan
Read More
MedImmune and Mirati to conduct trial combining durvalumab and mocetinostat
Read More
Anavex Life Sciences discloses preliminary phase IIa results for Anavex 2-73
Read More
Pharmaxis and Synairgen form collaboration to target LOXL2 for IPF
Read More